白雲山(00874.HK):廣州醫藥出售應收賬款
格隆匯4月28日丨白雲山(00874.HK)公吿,於2021年8月13日,公司的子公司廣州醫藥與興證資管簽訂《興業圓融-廣州醫藥應收賬款2期資產支持專項計劃基礎資產買賣協議》,發行規模為人民幣10億元,據此,廣州醫藥於2021年9月10日與興證資管簽訂《交割確認函》,廣州醫藥確認向興證資管出售2期初始基礎資產,並收到購買價款人民幣10億元("交易H");廣州醫藥於2021年10月28日與興證資管簽訂《新增基礎資產交割確認函》,廣州醫藥確認向興證資管出售第一次新增基礎資產,並收到購買價款人民幣6.52億元("交易I");廣州醫藥於2022年1月28日與興證資管簽訂《新增基礎資產交割確認函》,廣州醫藥確認向興證資管出售第二次新增基礎資產,並收到購買價款人民幣7.53億元("交易J");廣州醫藥於2022年4月28日與興證資管簽訂《新增基礎資產交割確認函》,廣州醫藥確認向興證資管出售第三次新增基礎資產,並收到購買價款人民幣5.99億元("交易K")。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.